Shareholders are prompted to vote before the voting deadline authorized by the shareholder
10:00 am (Mountain Time) entry 9 November 2020
EDMONTON, AB, November 6, 2020 / CNW / – Aurora Cannabis Inc. (“Company”; or “dawn“) (NYSE: ACB) (TSX: ACB), a Canadian company that determines the future of cannabinoids worldwide, reminds shareholders to vote for the resolutions to be voted at the Annual General Meeting of Shareholders. and the special general meeting of shareholders of the Company (the “Meeting“) before the proxy’s voting deadline 10:00 am (Mountain Time) on MondayNovember 9, 2020.
Meetings will be held on Thursday, November 12, 2020 in 10:00 am (Mountain Time). Due to the global COVID-19 public health emergency, it will be held for the first time in a virtual-only format, via the live webcast at https://web.lumiagm.com/242822694. A virtual-only meeting is being passed this year to give all shareholders an equal opportunity to participate in the meeting regardless of their geographic location or specific constraints, circumstances or risks. they may be faced by COVID-19.
Aurora’s Board of Directors unanimously recommends shareholders to vote FOR
All proposed resolutions will be voted on at the General Meeting.
Aurora shareholders are encouraged to read the meeting documentation details and vote before the proxy voting deadline. A copy of the meeting documents and instructions on how to attend and vote can be found at the Virtual Meeting on the Aurora profile on SEDAR or on the Aurora website at https://investor.auroramj.com/ about-aurora / corporate-governance /.
Your vote is important! Vote today!
How to vote and shareholder questions
To ensure that your shares will be voted on at the meeting, shareholders are encouraged to vote online or by phone prior to the authorization limit. 10:00 am (Mountain Time) on 9 November 2020.
INTERNET: Vote online at www.investorvote.com using the control number located on the authorization form.
PHONE: Toll free 1-866-732-VOTE (8683).
INTERNET: Vote online at www.proxyvote.com using the control number found on the voting guide form.
PHONE: Call 1-800-474-7493 (ENGLISH) OR 1-800-474-7501 (FRANCE).
Shareholders with questions about meeting resolutions or needing assistance with voting can contact the Laurel Hill Advisory Team, Aurora strategic advisor and agent at:
Advisory Group Laurel Hill
North America is free: 1-877-452-7184
About Aurora Cannabis Inc.
Aurora is a global leader in the cannabis industry serving both the medical and consumer markets. Head office Edmonton, Alberta, Aurora is a pioneer in the global cannabis sector dedicated to helping people improve their lives. The Company’s portfolio of brands includes Aurora, Aurora Drift, San Rafael ’71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler and Reliva. Providing customers with innovative, high-quality cannabis and hemp products, Aurora brands continue to break out into industry leaders in the medical, performance, wellness, and medical markets. location wherever they are marketed. For more information please visit our website at www.auroramj.com.
This bulletin contains statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements “). A forward-looking statement is often characterized by words like “plan”, “continue”, “expect”, “project”, “plan”, “believe”, “anticipate”, ” estimates “,” possibly “,” will “,” potential “,” proposals “and other similar words, or statements that certain events or conditions are” possible “or” will ” happening. These forward-looking statements are just predictions. Various assumptions have been used to make conclusions or to make predictions in forward-looking statements throughout this newsletter. Forward statements based on management’s opinions, estimates and assumptions based on management’s experience and perception of historical trends, current conditions and expected developments At the time of making statements, such as current and future market conditions, current and future regulatory environment and future approvals and licenses. Prospective statements contain risks, uncertainties and other factors that management deems relevant and reasonable in the circumstances that may cause events, actual outcomes, performance, performance, outlook, opportunity or performance other than those forecasted in forward-looking statements, including general business and economic conditions, changes in law and regulation specifications, product needs, price changes of essential commodities, competition and other risks, uncertainties and factors listed under the heading “Risk factors” Annual information form the company’s date September 24, 2020 (the “AIF“) and is submitted to Canadian securities regulators that are on the Company’s issuer profile on SEDAR at www.sedar.com. The Company warns that its list of risks, uncertainty and Other factors described in the AIF are incomplete and other factors that may adversely affect its results Readers are encouraged to carefully consider risks, uncertainties, and assumptions. in evaluating forward-looking statements and warned not to rely excessively on such information.The Company has no obligation and expressly disclaims any intent or obligation, to update or amend any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities laws.
SOURCE Aurora Cannabis Inc.
See original content: http://www.newswire.ca/en/releases/archive/November2020/06/c3312.html